جستجوی استاد راهنمای دانشگاهی

• Cell Biology
• Molecular Genetics
• Cytoskeleton Dynamics
• +۳ مورد دیگر

Prof. Dr. Oliver J. Gruß serves as Professor of Genetics, Head of the Department of Cell Division, and Chairman of the Biology Department at the University of Bonn's Institute of Genetics. His research explores microtubule functions in eukaryotic cytoskeleton dynamics during interphase and mitosis. Education: Diploma in Biochemistry, University of Regensburg (1994) Doctorate in Molecular Cell Biology, Ruprecht-Karls-University of Heidelberg (1998) Postdoctoral Research, European Molecular Biology Laboratory (EMBL), Heidelberg Research Group Leader and Temporary Professor, Center for Molecular Biology, University of Heidelberg Professor of Genetics, University of Bonn (since 2015) Research Interests: His work focuses on microtubule-binding proteins (MAPs) regulating spindle assembly and chromosome segregation during mitosis, alongside SMN complex functions in cellular stress response and spinal muscular atrophy mechanisms. The lab employs super-resolution microscopy, real-time imaging, and biochemical reconstitution in cell-free systems to investigate cytoskeletal organization and RNP homeostasis. Scientific Awards: President of the German Society for Cell Biology (2021) Teaching Award of the University of Bonn for curriculum development (2020) Golden Microscope Teaching Award from Biology Department (2021) Grants and Leadership: Currently leads DFG-funded projects on SMN complex condensation in RNP homeostasis (2022-2023) and MTUS1-mediated microtubule bundles (2023), plus Cure SMA Europe research since 2022. Served as DGZ President (2018-2020) and board member (2012-2020). Laboratory: Directs the Working Group (AG Gruß) at the Institute of Genetics, specializing in cytoskeleton dynamics through advanced microscopy and structural analysis of cell division mechanisms.

• Protein Structure
• DNA Repair Mechanisms
• Genome Instability
• +۵ مورد دیگر

Dr. Dea Slade is a faculty member at the University of Vienna, affiliated with Max Perutz Labs and the Department of Biochemistry and Cell Biology within the Faculty of Life Sciences. With an active research career spanning from 2012 to the present, Dr. Slade serves as principal investigator on multiple research projects including the currently active "Genome Instability" project (2024-2028) and previously led the "Structural and functional characterization of SPOC domains" project (2019-2022). Dr. Slade's research focuses on protein structure, DNA repair mechanisms, and genome instability. Their work contributes to several UN Sustainable Development Goals, particularly those related to health and well-being. Key research areas include protein tertiary structure, glycosidase function, cell-cycle regulation, and DNA-damage response mechanisms. Their fingerprint analysis reveals significant expertise in Protein Tertiary Structure (100%), Glycosidase (80%), C-Terminus (75%), Proliferating Cell Nuclear Antigen (70%), Polymerase (65%), and Histone-related research (50%). Dr. Slade has published 16 research articles with recent publications appearing in high-impact journals including Nature Photonics (2024), EMBO Molecular Medicine (2023), and Genes and Development (2023). Their publication record shows consistent output from 2016 through 2024, with multiple publications per year in recent periods. Research trends indicate a strong focus on molecular mechanisms of DNA repair, protein domain functionality, and cellular responses to genomic stress. Dr. Slade has secured research funding for seven projects, including six completed and one currently active. Their collaborative network spans multiple institutions and countries, with recent external collaborations visible at the country/territory level. The "Genome Instability" project involves collaborators including Campbell, Bulgheresi, Dammermann, Jantsch, Ellis, Matos, Obenauf, and Schlögelhofer. Dr. Slade maintains an active research profile with media engagement, including a 2016 press contribution titled "DNA-Schäden: Wenn der zelluläre Notfalldienst versagt" (DNA Damage: When the Cellular Emergency Service Fails), which was picked up by 8 news outlets, blogged by 1 source, and shared by numerous social media users.

• Chronobiology
• Marine Biology
• Crustacean Endocrinology
• +۵ مورد دیگر

David Wilcockson is a Reader at Aberystwyth University’s Department of Life Sciences, specializing in biological clocks in marine organisms and crustacean endocrinology. He leads the Aquatic, Behavioural & Evolutionary Biology (ABEB) research group, focusing on molecular mechanisms of circatidal (~12.4h) and circadian (~24h) rhythms in intertidal animals like Eurydice pulchra and Talitrus saltator . His work, funded by BBSRC, MRC, and NERC, involves collaborations with University of Leicester, Bangor University, and Cambridge LMB. His research spans chronobiology (clock genes), marine ecology (lobster habitat use in wind farms), endocrinology (bursicon in crustaceans), and behavioral biology (polarized light navigation). Recent articles highlight interactions between artificial light and migration , neuropeptide regulation of molting , and one health applications of circadian medicine. Wilcockson has served as Principal Investigator on 11 externally funded projects (2013–2026), including studies on offshore wind farm habitats , dolphin conservation , and salmon smolt tracking . Media coverage includes BBC documentaries, Nature and Science News features, and policy references.

Alal Eranمشاهده پروفایل

پژوهشگر

• Computational Biology
• Neurodevelopmental Disorders
• Genomics
• +۵ مورد دیگر

Alal Eran is a computational biologist at Boston Children's Hospital, part of the Computational Health Informatics Program. Her research focuses on the molecular basis of neurodevelopmental disorders, particularly autism, integrating genomic and clinical data to understand gene-environment interactions. She investigates RNA-mediated regulation at synapses, A-to-I RNA editing levels, and mitochondrial RNA modifications influenced by environmental factors like UV exposure. Her work aims to improve early diagnosis and personalized care for children with autism. Key research areas include computational biology, precision medicine, and systems biology. She explores diagnostic biomarkers, disease comorbidities, and the impact of early infections and antibiotic use on neurodevelopmental outcomes. Her expertise spans bioinformatics tools for genomic analysis and clinical data integration, such as the i2b2 platform. Publications highlight her contributions to understanding autism subtypes, mitochondrial gene expression, and the sociocultural impacts of vaccines. She has also contributed to studies on inflammatory bowel disease (IBD) pathogenesis and racial disparities in pandemic outcomes. No scientific awards or advising activities are documented in the provided text. Labs/Teams: Member of the Computational Health Informatics Program at Boston Children's Hospital.

• Antimicrobial Agents
• Antiviral Chemistry
• Drug Repurposing
• +۴ مورد دیگر

Dr. Ibrahim Mustafa El-Deeb is a Senior Research Fellow at Griffith University's Institute for Biomedicine and Glycomics. His research focuses on developing novel antimicrobial and antiviral agents, particularly targeting drug-resistant pathogens and repurposing existing drugs for new therapeutic applications. He is actively involved in projects addressing antibiotic resistance mechanisms, neuraminidase inhibitor design, and zinc ionophore-based therapies. Key research areas include: Design of antiviral agents targeting human parainfluenza virus Development of synergistic antibiotic combinations Repurposing neurodegenerative drugs for antimicrobial use Metal ionophore mechanisms in bacterial pathogenesis El-Deeb has secured significant funding through grants such as the NHMRC Ideas Grant (2024-2027) for combating multidrug-resistant gonorrhoea and the Cumming Global Centre for Pandemic Therapeutics Grant (2024-2027) for neuraminidase inhibitor development. His work has been published in high-impact journals including Science Translational Medicine, mBio, and Antiviral Research. Recent studies highlight breakthroughs in reversing antibiotic resistance through zinc ionophore mechanisms and synergistic drug combinations. He currently supervises doctoral research on novel antimicrobial and neuraminidase inhibitor synthesis at Griffith University.

• Cancer Glycobiology
• Biochemistry
• Cell Biology
• +۷ مورد دیگر

Dr. Andrea Maggioni is a Research Fellow in Cancer Glycobiology at Griffith University's Institute for Biomedicine and Glycomics. He holds a BSc (Honors) in Molecular and Cell Biology from Università degli Studi di Milano and a PhD in Biomedical Sciences from Griffith University. His research focuses on glycobiology, cancer biology, and antiviral therapies, with notable contributions to understanding glycan-receptor interactions, viral entry mechanisms, and enzyme inhibitors. Education: BSc (Hons), Molecular and Cell Biology, Università degli Studi di Milano (2001) PhD, Griffith University (2011) Certificate in Immunology, Harvard Medical School (2024–present) Research Interests: Andrea's work bridges glycobiology and biomedical applications, including cancer immunotherapy biomarkers, viral pathogenesis (e.g., rotavirus, parechovirus), and drug design targeting enzymes like sialidase. He explores glycosylation roles in stem cell biology and employs advanced techniques such as NMR spectroscopy and mass spectrometry. Grants & Projects: Leading a $250k grant to study melanoma biomarkers (Hay Family Benevolent Fund, 2023–2028) Co-investigator on $498k equipment grant for glycobiology research (Griffith University, 2023) Previous funding from Society for Glycobiology (2014 Travel Award) and Laing O'Rourke (2015) Supervision: Associate supervisor for six ongoing doctoral/master's projects on topics like exosome glycointeractomes and cancer enzyme inhibition strategies. Awards: 2014 Travel Award, Society for Glycobiology Labs & Affiliations: Active in Griffith's Institute for Biomedicine and Glycomics, focusing on translational research in glycobiology and cancer. Collaborates internationally on antiviral drug discovery and immune modulation studies.

Zhi Tanمشاهده پروفایل

استادیار

• Drug Discovery
• Computational Chemistry
• Cancer Therapeutics
• +۳ مورد دیگر

Zhi Tan, M.D., Ph.D., is an Assistant Professor at Baylor College of Medicine, holding joint appointments in the Department of Pharmacology and Chemical Biology and the Center for Drug Discovery. He is affiliated with the Jan and Dan Duncan Neurological Research Institute in Houston, TX. Dr. Tan earned his MD from Wuhan University (2012) and a PhD from the University of Texas MD Anderson Cancer Center and UT Health Graduate School of Biomedical Sciences (2018). His research focuses on leveraging computational chemistry, bioinformatics, and chemical biology to develop novel therapeutics for diseases such as cancers. Key areas include small molecule inhibitors for targeted therapy, computational algorithms for drug discovery, and RNA-protein interaction modulators. His lab has secured significant funding, including a $2M CPRIT First Time Tenure Track Faculty Award (2022–2027) to advance drug discovery efforts. Notable publications highlight breakthroughs in noncoding RNA modulation, SARS-CoV-2 protease inhibitors, and epigenetic drivers of glioblastoma progression. Lab members include Assistant Professor Fei Yuan, and collaborations span diverse disciplines from informatics to synthetic chemistry. The lab’s translational focus bridges basic science and clinical applications, with ongoing projects targeting enzyme activation pathways and male contraception mechanisms.

Aleksandar Milosavljevicمشاهده پروفایل

استاد

• Genomics
• Cancer Genomics
• Bioinformatics
• +۴ مورد دیگر

Aleksandar Milosavljevic is a Professor and holds the Henry and Emma Meyer Chair in Molecular Genetics at Baylor College of Medicine. He serves as Director of the Program in Quantitative & Computational Biosciences (QCB) and Co-Director of the Computational and Integrative Biomedical Research Center (CIBR). He is also a member of the Dan L Duncan Comprehensive Cancer Center. His research focuses on genomics, epigenomics, and bioinformatics, with a particular emphasis on cancer genomics, extracellular RNA communication, and clinical genome interpretation. Education: PhD from University of California, Santa Cruz (1990). Research interests include developing computational methods for analyzing genomic and epigenomic data, constructing biological atlases (e.g., Human Epigenome Atlas, exRNA Atlas), and advancing clinical genomic applications through projects like ClinGen. His work bridges basic science and translational medicine, with contributions to understanding tumor biology, genetic variant interpretation, and liquid biopsy technologies. Key projects include the NIH Roadmap Epigenomics Initiative, NIH Extracellular RNA Communication Consortium, and ClinGen, which developed tools like the Pathogenicity Calculator and Allele Registry. His lab collaborates widely, addressing challenges in structural genomics, stochastic epigenetic regulation, and precision medicine.

Yida Anمشاهده پروفایل

مدرس

• Music Performance
• Violin
• Chamber Music
• +۳ مورد دیگر

Yida An is a Project Instructor at the Butler School of Music, University of Texas at Austin. He holds an Artist Diploma from Butler School of Music (studying with Brian Lewis), a Master of Music from Bard College Conservatory of Music (under Gil Shaham and Adele Anthony), and a Bachelor of Music from Central Conservatory of Music in Beijing (under Xie Haoming). His musical career includes roles as concertmaster of the Bard College Symphony Orchestra and solo performances with renowned conductors like Tan Dun and Leon Botstein. He has collaborated on major venues including Carnegie Hall and Lincoln Center, and organized solo recitals in New York. His performances span classical violin repertoire, chamber music, and orchestral collaborations, emphasizing both traditional and contemporary works. Education history includes Beijing Eastbank Academy of Music (2017-2018) and extensive touring with the Central Conservatory of Music Youth Symphony Orchestra. Notable collaborations include working with composer Joan Tower and participating in the Bard Music Festival. His musical contributions highlight technical mastery and artistic interpretation across diverse genres. While primarily focused on performance, his academic affiliations also involve interdisciplinary research in RNA biology and molecular mechanisms, as evidenced by publications in high-impact journals. These articles explore topics like group II intron mobility, exosome-mediated RNA sorting, and therapeutic applications of RNA sequencing technologies, showcasing a dual expertise in music and life sciences.

• Neuroanatomy
• Retina
• Ophthalmology
• +۴ مورد دیگر

Associate Professor Ulrike Grunert is a distinguished researcher in the Faculty of Medicine and Health at the University of Sydney, where she serves in the Clinical Ophthalmology and Eye Health department at the Save Sight Institute. With over three decades of experience in visual neuroscience, her work has significantly advanced our understanding of retinal structure and function. Dr. Grunert received her PhD in Biology from Johann Wolfgang Goethe University in Frankfurt, Germany in 1985, followed by postdoctoral work at the University of Florida. She became a group leader at the Max-Planck-Institute for Brain Research before joining the University of Sydney in 1994 with a Feodor Lynen fellowship from the Alexander von Humboldt Foundation. She was awarded her Habilitation from Goethe University in 1994 and has maintained continuous research activity since then, with appointments including Lions Vision Research Fellow (2003-2009) and Honorary Principal Research Fellow at the University of Melbourne (2006). Her research focuses on the functional neuroanatomy of the mammalian retina, with special emphasis on the primate retina. Dr. Grunert's work has been instrumental in defining the neural circuitry of the eye , particularly related to retinal ganglion cells and their connections with other retinal cells and targets in the brain. Her laboratory employs advanced techniques including immunohistochemistry, confocal microscopy, and single-cell transcriptomics to investigate retinal cell types and their functional organization. Analysis of her recent publications reveals a consistent research trajectory focused on characterizing retinal cell types across primate species, with increasing emphasis on molecular markers and comparative approaches. Her work spans from fundamental cellular organization to translational applications in vision science, with particular attention to the human fovea and specialized retinal pathways. Her scientific achievements have been recognized with prestigious awards including: National Vision Research Institute Fellowship (2020) Nina Kondelos Award of the Australian Neuroscience Society (2017) Sydney Medical Foundation Fellowship (2017-2021) Lions Vision Research Fellowship (2003-2009) Dr. Grunert has successfully supervised numerous students and collaborated extensively with international researchers. Her grant portfolio includes multiple NHMRC Project Grants, ARC Centre of Excellence funding, and equipment grants supporting advanced retinal imaging. She currently leads research on retinal gene therapy delivery, mapping the human retina, and night vision pathways, often in collaboration with international partners in Italy, Japan, and the United States. Her laboratory at the Save Sight Institute maintains state-of-the-art facilities for retinal histology, confocal microscopy, and molecular analysis.

• Malaria Research
• Parasitology
• Molecular Biology
• +۲ مورد دیگر

Prof. Gabriele Pradel is a University Professor at RWTH Aachen University specializing in malaria research. Her work focuses on the molecular biology of Plasmodium falciparum, including mechanisms of host cell invasion, chromatin regulation, and parasite transmission. Institution: RWTH Aachen University Email: pradel@bio2.rwth-aachen.de Research Interests: • Malaria pathogenesis and transmission • Parasitic protein interactions • Epigenetic regulation in Plasmodium Recent Article Trends: Recent publications emphasize antimalarial drug development (e.g., synthetic alkaloid analogs), chromatin modulation networks (SET10 methyltransferase), and host-parasite interactions involving complement evasion and plasma proteins. Studies on gametocyte egress and LCCL domain proteins highlight transmission biology.

Michael D Toneyمشاهده پروفایل

استاد

• Enzyme Mechanisms
• Vitamin B6 Enzymology
• Chemical Biology
• +۲ مورد دیگر

Michael D Toney is a Professor in the Department of Chemistry at UC Davis. He received his Ph.D. from UC Berkeley (1990) and B.S. from University of Alabama (1985). His research group investigates enzymatic catalysis with focus on vitamin B6-dependent enzymes. Research Focus: Uses experimental and computational methods to explore: Catalytic rate enhancements and reaction specificity in enzymes Stereoelectronic effects in biocatalysis Light-activated enzyme mechanisms Protein-based nanomaterial design Publication Trends: Recent work spans structural biology, antiviral protein engineering, and nanomaterial synthesis, demonstrating multidisciplinary approaches to biochemical problems. Laboratory & Advising: Leads active research group focused on enzyme mechanisms and protein engineering. Encourages undergraduate participation in research projects.

• Computational Structural Biology
• Statistical Machine Learning
• DNA Shape Prediction
• +۴ مورد دیگر

Remo Rohs is a tenured Professor of Quantitative and Computational Biology, Chemistry, Physics and Astronomy, Computer Science, and Biomedical Engineering at the University of Southern California Dornsife College. He leads the Rohs Lab, focusing on integrating genomics and structural biology to uncover molecular mechanisms in gene regulation. Chair, Department of Quantitative and Computational Biology (2021–2024) Section Head, Quantitative and Computational Biology (2018–2020) Full Professor with Tenure at USC (2016–present) Research Interests center on: Computational structural biology DNA shape prediction Protein-DNA recognition mechanisms Epigenetic effects on binding specificity RNA structure modeling High-throughput genomic analysis His work combines artificial intelligence , molecular simulations , and experimental validation to study transcription factors and chromatin structure. Recent publications highlight deep learning methods for DNA/RNA structure prediction and database development for molecular interactions. Scientific Awards include: Sloan Research Fellowship (2013–2017) Multiple RECOMB/ISCB Top-Paper Awards (2012–2017) American Chemical Society OpenEye Outstanding Junior Faculty Award (2015–2016) USC Mentoring Award (2015–2016) He has supervised 13 PhD graduates and published 92+ peer-reviewed papers . His lab develops tools like DNAproDB and TFBSshape for structural analysis of nucleic acid complexes.

Charles Emerson Murryمشاهده پروفایل

استاد

• Stem Cell Biology
• Regenerative Medicine
• Cardiovascular System Differentiation
• +۵ مورد دیگر

Dr. Charles (Chuck) Murry is Professor of Stem Cell Biology and Regenerative Medicine, Pathology, Medicine, and Biomedical Engineering at the University of Southern California. He serves as Chair of the Department of Stem Cell Biology and Regenerative Medicine and Director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the Keck School of Medicine of USC. Previously, he was a professor at the University of Washington School of Medicine for 28 years, where he directed the Institute for Stem Cell and Regenerative Medicine. Dr. Murry earned his BS in chemistry from the University of North Dakota and both his PhD and MD degrees from Duke University. He completed residency training in Pathology at the University of Washington, followed by fellowship training in vascular biology and diagnostic cardiovascular pathology. Dr. Murry's research focuses on stem cell biology with an emphasis on understanding differentiation of the human cardiovascular system and using these cells to study diseases and regenerate damaged tissues. His laboratory is a world leader in heart regeneration, working toward clinical trials using cardiomyocyte therapy. His work spans basic science to translational applications, with particular expertise in cardiac tissue engineering, stem cell differentiation, and developing therapies for heart failure and cardiovascular disease. Analysis of Dr. Murry's recent publications reveals a strong focus on advancing cardiac regenerative medicine through multiple approaches. His research spans stem cell biology, tissue engineering, genetic engineering, and clinical translation. Key themes include improving cardiomyocyte engraftment and maturation, developing vascular networks for engineered tissues, addressing arrhythmia risks in cell therapy, and applying precision medicine approaches to cardiac diseases. Dr. Murry has received numerous scientific awards and honors, including: Fellow of the American Academy for the Advancement of Science Fellow of the American Institute for Medical and Biological Engineering American Heart Association's Golden Heart Award Multiple recognitions for excellence in education from the University of Washington School of Medicine Recognition for entrepreneurial abilities from the University of Washington School of Medicine Member of the Association of American Physicians As a dedicated mentor, Dr. Murry has guided more than 100 postdoctoral scholars, graduate students, and undergraduates throughout his career. His research has been continuously funded by the National Institutes of Health as a principal investigator since 1996. He has cofounded several biotechnology companies including BEAT Biotherapeutics, Sana Biotechnology, and StemCardia to translate his laboratory discoveries into clinical applications. Dr. Murry leads the Murry Lab, which focuses on stem cell biology, cardiovascular differentiation, and heart regeneration. The lab works on translating preclinical research by pursuing scaled-up manufacturing processes and investigating electrophysiology and immunology to overcome challenges in cell therapy. The lab is also part of the broader USC Stem Cell initiative, which includes collaborations across multiple departments and institutions in the Los Angeles area.

Iddo Hellerمشاهده پروفایل

استادیار

• Single-molecule biophysics
• DNA-protein interactions
• Ice-binding proteins
• +۴ مورد دیگر

Dr. Iddo Heller is an Assistant Professor in the Department of Physics and Astronomy at Vrije Universiteit Amsterdam, leading the Heller Lab focused on single-molecule biophysics. He holds a PhD in nanotechnology and quantum transport from Delft University of Technology and has pioneered methodologies combining optical tweezers with super-resolution microscopy. His work explores DNA-protein interactions, ice-binding proteins, and cryoprotection mechanisms. He has received NWO VENI and VIDI grants for his innovative research. Education: MSc in Applied Physics, Delft University of Technology PhD in Nanotechnology & Biosensing, Delft University of Technology Research Interests: Physics of DNA intercalation and structural transitions Mechanisms of ice-binding proteins in cryoprotection Single-molecule analysis of DNA repair/replication Development of advanced biophysical instrumentation Key Achievements: Pioneered super-resolution microscopy in optical tweezers (2011 VENI grant) Co-developed STED microscopy with optical tweezers for protein-DNA dynamics Recipient of 2017 NWO VIDI Grant for ice-binding protein research Scientific advisor to LUMICKS B.V., advancing nanomanipulation technologies Advising & Grants: Supervised 1 PhD thesis to date Active in interdisciplinary collaborations across physics, biology, and engineering Develops cutting-edge methodologies for biomolecular analysis Labs & Teams: Heller Lab at VU Amsterdam focuses on quantitative single-molecule biophysics Collaborates with LUMICKS on commercial instrumentation development